Skip to main content
News

Major Recall of BP Medication Launched


February 22, 2016

 

The U.S. Food and Drug Administration (FDA) announced the recall of more than 275,000 bottles of candesartan cilexetil tablets, 16 mg.

The Class III recall was launched after the tablets failed the impurities/degredation specifications at nine months, according to the report.

The drugs in question were manufactured by Indian drug manufacturer Mylan Laboratories for Sandoz of Princeton, New Jersey. 

The following presentations are being recalled: 

Pills per bottle

NDC

30-count bottle

00781-5938-31

90-count bottle

00781-5938-92

Mylan has had a number of recalls in the recent past. Last week, the FDA announced the recall of a controlled substance made by Mylan. In August, 60,000 vials of two cancer medications were recalled.  

Indian drug manufacturing has had its share of woes. Click here to read more.

Click here to read the FDA’s report about this recall.

 

--Stephanie Vaccaro

 

Reference:

1. U.S. Food and Drug Administration. Enforcement Report – Week of February 17, 2016. www.fda.gov. Accessed February 22, 2016.

 

 

 

 

Back to Top